Sensient Technologies (SXT)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
$134.84-1.07%
Close 2026-09-04 · 1-day change
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
QuarterlyIQ Insights · SXT
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenues | 1,703.5 | 1,612.1 | 1,557.2 | 1,456.5 | 1,437.0 | 1,380.3 | 1,332.0 | 1,322.9 | 1,386.8 | 1,396.5 | 1,421.1 | 1,412.5 | 1,489.4 | 1,509.5 | 1,453.6 | 1,430.8 | 1,328.2 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 1,396.5 | 1,421.1 | 1,412.5 | 1,489.4 | 1,509.5 | — | — | — |
| Cost of Revenues | 1,113.3 | 1,072.8 | 1,050.1 | 996.2 | 947.9 | 925.6 | 908.3 | — | — | — | — | — | — | — | — | — | — |
| Operating Expenses & Income | |||||||||||||||||
| Selling, General & Admin | 350.9 | 332.2 | 315.5 | 305.3 | 292.4 | 284.6 | 271.1 | 293.8 | 262.8 | 307.7 | 289.8 | 288.1 | 357.8 | 301.3 | 269.8 | 258.8 | 233.8 |
| R&D Expenses | — | 52.9 | 49.1 | 48.1 | 42.2 | 34.3 | 38.5 | 40.1 | 43.0 | 40.9 | 40.9 | 35.1 | 35.9 | 34.1 | 34.2 | 33.2 | — |
| Operating Income | 239.3 | 207.1 | 191.6 | 155.0 | 196.8 | 170.0 | 152.7 | 121.1 | 203.4 | 167.8 | 185.6 | 166.3 | 130.7 | 173.8 | 192.9 | 190.8 | 174.6 |
| Earnings from Continuing Operations | |||||||||||||||||
| Interest Expense | 30.9 | 29.6 | 28.8 | 25.2 | 14.5 | 12.5 | 14.8 | 20.1 | 21.9 | 19.4 | 18.3 | 16.9 | 16.1 | 16.1 | 16.9 | 19.4 | 20.4 |
| EBT, Incl. Unusual Items | 208.4 | 177.5 | 162.8 | 129.9 | 182.2 | 157.5 | 137.8 | 101.0 | 181.5 | 148.4 | 167.3 | 149.4 | 114.6 | 157.6 | 176.0 | 171.4 | 154.2 |
| Income Tax Expense | 50.4 | 43.1 | 38.1 | 36.5 | 41.3 | 38.7 | 28.4 | 19.0 | 24.2 | 58.8 | 44.4 | 42.1 | 32.8 | 43.3 | 50.9 | 50.9 | 47.0 |
| Net Income | |||||||||||||||||
| Net Income | 158.0 | 134.5 | 124.7 | 93.4 | 140.9 | 118.7 | 109.5 | 82.0 | 157.4 | 89.6 | 126.3 | 106.8 | 73.6 | 113.3 | 123.9 | 120.5 | 107.1 |
| Per Share | |||||||||||||||||
| Basic EPS | 3.73 | 3.18 | 2.96 | 2.22 | 3.36 | 2.82 | 2.59 | 1.94 | 3.71 | 2.05 | 2.84 | 2.33 | 1.52 | 2.28 | 2.50 | 2.42 | 2.18 |
| Diluted EPS | 3.69 | 3.16 | 2.94 | 2.21 | 3.34 | 2.81 | 2.59 | 1.94 | 3.70 | 2.03 | 2.82 | 2.31 | 1.51 | 2.27 | 2.49 | 2.41 | 2.17 |
| Revenue per Share | 39.84 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 42.4 | 42.2 | 42.1 | 42.0 | 41.9 | 42.1 | 42.3 | 42.3 | 42.4 | 43.8 | 44.5 | 45.9 | 48.5 | 49.8 | 49.6 | 49.7 | 49.1 |
| Diluted Weighted Avg Shares | 42.8 | 42.6 | 42.4 | 42.2 | 42.2 | 42.3 | 42.3 | 42.3 | 42.5 | 44.0 | 44.8 | 46.2 | 48.8 | 49.9 | 49.8 | 49.9 | 49.4 |
| Supplemental | |||||||||||||||||
| EBITDA | — | 268.2 | 251.9 | 212.8 | 249.2 | 222.1 | 202.3 | 176.1 | 256.6 | 216.3 | 232.6 | 214.3 | 182.1 | 225.8 | 241.2 | 236.9 | 218.0 |
| EBIT | 239.3 | 207.1 | 191.6 | 155.0 | 196.8 | 170.0 | 152.7 | 121.1 | 203.4 | 167.8 | 185.6 | 166.3 | 130.7 | 173.8 | 192.9 | 190.8 | 174.6 |
| Effective Tax Rate | 24.2% | — | — | 28.1% | 22.7% | 24.6% | 20.6% | 18.8% | 13.3% | 39.6% | 26.5% | 28.2% | 28.6% | 27.5% | 28.9% | 29.7% | 30.5% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.